company background image
YGEN

Yourgene Health AIM:YGEN Stock Report

Last Price

UK£0.047

Market Cap

UK£34.2m

7D

-1.1%

1Y

-67.0%

Updated

04 Oct, 2022

Data

Company Financials +
YGEN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

YGEN Stock Overview

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally.

Yourgene Health Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Yourgene Health
Historical stock prices
Current Share PriceUK£0.047
52 Week HighUK£0.16
52 Week LowUK£0.045
Beta0.81
1 Month Change-24.80%
3 Month Change-24.80%
1 Year Change-67.02%
3 Year Change-60.00%
5 Year Change-37.33%
Change since IPO-70.63%

Recent News & Updates

Sep 22
Yourgene Health Plc (LON:YGEN) Shares Could Be 34% Above Their Intrinsic Value Estimate

Yourgene Health Plc (LON:YGEN) Shares Could Be 34% Above Their Intrinsic Value Estimate

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Yourgene Health Plc...

Shareholder Returns

YGENGB Medical EquipmentGB Market
7D-1.1%3.7%1.6%
1Y-67.0%-19.1%-13.0%

Return vs Industry: YGEN underperformed the UK Medical Equipment industry which returned -19.9% over the past year.

Return vs Market: YGEN underperformed the UK Market which returned -14.4% over the past year.

Price Volatility

Is YGEN's price volatile compared to industry and market?
YGEN volatility
YGEN Average Weekly Movement6.2%
Medical Equipment Industry Average Movement6.0%
Market Average Movement5.5%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.9%

Stable Share Price: YGEN is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: YGEN's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000253Lyn Reeshttps://www.yourgene-health.com

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down’s syndrome, Edwards' syndrome, and Patau’s Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient’s response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing.

Yourgene Health Plc Fundamentals Summary

How do Yourgene Health's earnings and revenue compare to its market cap?
YGEN fundamental statistics
Market CapUK£34.17m
Earnings (TTM)-UK£1.92m
Revenue (TTM)UK£37.56m

0.9x

P/S Ratio

-17.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
YGEN income statement (TTM)
RevenueUK£37.56m
Cost of RevenueUK£16.20m
Gross ProfitUK£21.37m
Other ExpensesUK£23.28m
Earnings-UK£1.92m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0026
Gross Margin56.88%
Net Profit Margin-5.10%
Debt/Equity Ratio15.9%

How did YGEN perform over the long term?

See historical performance and comparison